Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Blog Pricing

Dr. Abraham Morgentaler

๐Ÿ‘ค Speaker
944 total appearances

Appearances Over Time

Podcast Appearances

BackTable Urology
Ep. 188 Testosterone Therapy Today: Clinical Advances and Safety with Dr. Abraham Morgentaler

I was just out of practice a few years. out of training a few years, and he says, what you're doing is dangerous. You have to stop. And I was brought in. I gave grand rounds in my own hospital to the endocrinologists. And a day or two later, I get a call from the Human Subjects Committee, the IRB, from the chief of the IRB. He says, Abe, we'd like you to come and talk to the IRB.

BackTable Urology
Ep. 188 Testosterone Therapy Today: Clinical Advances and Safety with Dr. Abraham Morgentaler

I was just out of practice a few years. out of training a few years, and he says, what you're doing is dangerous. You have to stop. And I was brought in. I gave grand rounds in my own hospital to the endocrinologists. And a day or two later, I get a call from the Human Subjects Committee, the IRB, from the chief of the IRB. He says, Abe, we'd like you to come and talk to the IRB.

BackTable Urology
Ep. 188 Testosterone Therapy Today: Clinical Advances and Safety with Dr. Abraham Morgentaler

So they arrange a time. I go in. I don't really know what it's all about. He says, we heard that you're practicing dangerous medicine. And it came, I know it came from one of the endocrinologists that I had spoken to. And you know what's funny is that that was early days.

BackTable Urology
Ep. 188 Testosterone Therapy Today: Clinical Advances and Safety with Dr. Abraham Morgentaler

So they arrange a time. I go in. I don't really know what it's all about. He says, we heard that you're practicing dangerous medicine. And it came, I know it came from one of the endocrinologists that I had spoken to. And you know what's funny is that that was early days.

BackTable Urology
Ep. 188 Testosterone Therapy Today: Clinical Advances and Safety with Dr. Abraham Morgentaler

So they arrange a time. I go in. I don't really know what it's all about. He says, we heard that you're practicing dangerous medicine. And it came, I know it came from one of the endocrinologists that I had spoken to. And you know what's funny is that that was early days.

BackTable Urology
Ep. 188 Testosterone Therapy Today: Clinical Advances and Safety with Dr. Abraham Morgentaler

And the most dangerous thing that I had done then, which was part of my lectures, I mean, I was giving talks on this thing because it was interesting to people. was I gave testosterone to men who on prostate biopsy had been diagnosed with PIN, with high-grade prostatic interpithelial neoplasia. At that time, we thought this was a pre-cancer.

BackTable Urology
Ep. 188 Testosterone Therapy Today: Clinical Advances and Safety with Dr. Abraham Morgentaler

And the most dangerous thing that I had done then, which was part of my lectures, I mean, I was giving talks on this thing because it was interesting to people. was I gave testosterone to men who on prostate biopsy had been diagnosed with PIN, with high-grade prostatic interpithelial neoplasia. At that time, we thought this was a pre-cancer.

BackTable Urology
Ep. 188 Testosterone Therapy Today: Clinical Advances and Safety with Dr. Abraham Morgentaler

And the most dangerous thing that I had done then, which was part of my lectures, I mean, I was giving talks on this thing because it was interesting to people. was I gave testosterone to men who on prostate biopsy had been diagnosed with PIN, with high-grade prostatic interpithelial neoplasia. At that time, we thought this was a pre-cancer.

BackTable Urology
Ep. 188 Testosterone Therapy Today: Clinical Advances and Safety with Dr. Abraham Morgentaler

And if a biopsy showed PIN, we automatically scheduled the next biopsy because we were sure there was prostate cancer hiding in there somewhere. Today, we barely care about PIN. Even if somebody has Gleason 6, which was absolute diagnosed cancer, at least that's how we thought of it then. Now we know maybe that doesn't deserve the designation of cancer. And in any case, it's low risk at worst.

BackTable Urology
Ep. 188 Testosterone Therapy Today: Clinical Advances and Safety with Dr. Abraham Morgentaler

And if a biopsy showed PIN, we automatically scheduled the next biopsy because we were sure there was prostate cancer hiding in there somewhere. Today, we barely care about PIN. Even if somebody has Gleason 6, which was absolute diagnosed cancer, at least that's how we thought of it then. Now we know maybe that doesn't deserve the designation of cancer. And in any case, it's low risk at worst.

BackTable Urology
Ep. 188 Testosterone Therapy Today: Clinical Advances and Safety with Dr. Abraham Morgentaler

And if a biopsy showed PIN, we automatically scheduled the next biopsy because we were sure there was prostate cancer hiding in there somewhere. Today, we barely care about PIN. Even if somebody has Gleason 6, which was absolute diagnosed cancer, at least that's how we thought of it then. Now we know maybe that doesn't deserve the designation of cancer. And in any case, it's low risk at worst.

BackTable Urology
Ep. 188 Testosterone Therapy Today: Clinical Advances and Safety with Dr. Abraham Morgentaler

But what's funny now is that this dangerous workout I was supposedly doing was because we've given it to 20 guys with PIN. and published it. And one guy eventually was biopsied and had cancer, but that was one out of 20 with, I forget what the follow-up was, but there wasn't much. So that was the dangerous work.

BackTable Urology
Ep. 188 Testosterone Therapy Today: Clinical Advances and Safety with Dr. Abraham Morgentaler

But what's funny now is that this dangerous workout I was supposedly doing was because we've given it to 20 guys with PIN. and published it. And one guy eventually was biopsied and had cancer, but that was one out of 20 with, I forget what the follow-up was, but there wasn't much. So that was the dangerous work.

BackTable Urology
Ep. 188 Testosterone Therapy Today: Clinical Advances and Safety with Dr. Abraham Morgentaler

But what's funny now is that this dangerous workout I was supposedly doing was because we've given it to 20 guys with PIN. and published it. And one guy eventually was biopsied and had cancer, but that was one out of 20 with, I forget what the follow-up was, but there wasn't much. So that was the dangerous work.

BackTable Urology
Ep. 188 Testosterone Therapy Today: Clinical Advances and Safety with Dr. Abraham Morgentaler

But what happened is that I developed a reputation around testosterone, and it's not just about sex, right? So in the mid to late 1990s, there was a movement that really emphasized health and wellness for people. The idea was that sort of the standard medical training was hospital-based, and that was really for what some people might call sick care.

BackTable Urology
Ep. 188 Testosterone Therapy Today: Clinical Advances and Safety with Dr. Abraham Morgentaler

But what happened is that I developed a reputation around testosterone, and it's not just about sex, right? So in the mid to late 1990s, there was a movement that really emphasized health and wellness for people. The idea was that sort of the standard medical training was hospital-based, and that was really for what some people might call sick care.

BackTable Urology
Ep. 188 Testosterone Therapy Today: Clinical Advances and Safety with Dr. Abraham Morgentaler

But what happened is that I developed a reputation around testosterone, and it's not just about sex, right? So in the mid to late 1990s, there was a movement that really emphasized health and wellness for people. The idea was that sort of the standard medical training was hospital-based, and that was really for what some people might call sick care.

BackTable Urology
Ep. 188 Testosterone Therapy Today: Clinical Advances and Safety with Dr. Abraham Morgentaler

You know, heart attacks, cancer treatments, things like that. But there were a lot of people who didn't need to be in a hospital, And they weren't feeling that good. And it wasn't just sex. You know, sometimes their mood was down or they felt weaker. They didn't feel like themselves. Energy was down from people who otherwise had led vigorous lives.

BackTable Urology
Ep. 188 Testosterone Therapy Today: Clinical Advances and Safety with Dr. Abraham Morgentaler

You know, heart attacks, cancer treatments, things like that. But there were a lot of people who didn't need to be in a hospital, And they weren't feeling that good. And it wasn't just sex. You know, sometimes their mood was down or they felt weaker. They didn't feel like themselves. Energy was down from people who otherwise had led vigorous lives.

BackTable Urology
Ep. 188 Testosterone Therapy Today: Clinical Advances and Safety with Dr. Abraham Morgentaler

You know, heart attacks, cancer treatments, things like that. But there were a lot of people who didn't need to be in a hospital, And they weren't feeling that good. And it wasn't just sex. You know, sometimes their mood was down or they felt weaker. They didn't feel like themselves. Energy was down from people who otherwise had led vigorous lives.